Clinical trials now up for Exscientia's world first AI-made drug
pharmaphorum - 30-Jan-2020Partnering with Japan's DSP, a milestone is reached in OCD treatment
Join the club for FREE to access the whole archive and other member benefits.
Canadian drug development company, AI therapeutics
Deep Genomics is using artificial intelligence to build a new universe of life-
The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.
Visit website: https://www.deepgenomics.com/
Details last updated 17-Feb-2020
Partnering with Japan's DSP, a milestone is reached in OCD treatment